Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA.
Department of Diagnostic and Interventional Radiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, 10117, Berlin, Germany.
Eur Radiol. 2022 Apr;32(4):2437-2447. doi: 10.1007/s00330-021-08337-3. Epub 2021 Oct 31.
The goal of this study was to investigate the effects of TACE using Lipiodol, Oncozene™ drug-eluting embolics (DEEs), or LUMI™-DEEs alone, or combined with bicarbonate on the metabolic and immunological tumor microenvironment in a rabbit VX2 tumor model.
VX2 liver tumor-bearing rabbits were assigned to five groups. MRI and extracellular pH (pH) mapping using Biosensor Imaging of Redundant Deviation in Shifts (BIRDS) were performed before and after intra-arterial therapy with conventional TACE (cTACE), DEE-TACE with Idarubicin-eluting Oncozene™-DEEs, or Doxorubicin-eluting LUMI™-DEEs, each with or without prior bicarbonate infusion, and in untreated rabbits or treated with intra-arterial bicarbonate only. Imaging results were validated with immunohistochemistry (IHC) staining of cell viability (PCNA, TUNEL) and immune response (HLA-DR, CD3). Statistical analysis was performed using Mann-Whitney U test.
pH mapping revealed that combining cTACE with prior bicarbonate infusion significantly increased tumor pH compared to control (p = 0.0175) and cTACE alone (p = 0.0025). IHC staining revealed peritumoral accumulation of HLA-DR antigen-presenting cells and CD3 + T-lymphocytes in controls. cTACE-treated tumors showed reduced immune infiltration, which was restored through combination with bicarbonate. DEE-TACE with Oncozene™-DEEs induced moderate intratumoral and marked peritumoral infiltration, which was slightly reduced with bicarbonate. Addition of bicarbonate prior to LUMI™-beads enhanced peritumoral immune cell infiltration compared to LUMI™-beads alone and resulted in the strongest intratumoral immune cell infiltration across all treated groups.
The choice of chemoembolic regimen for TACE strongly affects post-treatment TME pH and the ability of immune cells to accumulate and infiltrate the tumor tissue.
• Combining conventional transarterial chemotherapy with prior bicarbonate infusion increases the pH towards a more physiological value (p = 0.0025). • Peritumoral infiltration and intratumoral accumulation patterns of antigen-presenting cells and T-lymphocytes after transarterial chemotherapy were dependent on the choice of the chemoembolic regimen. • Combination of intra-arterial treatment with Doxorubicin-eluting LUMI™-beads and bicarbonate infusion resulted in the strongest intratumoral presence of immune cells (positivity index of 0.47 for HLADR-cells and 0.62 for CD3-cells).
本研究旨在探讨单纯使用载药微球 TACE(TACE 联合 OncozeneTM 载药微球或 LUMI™-载药微球)、载药微球 TACE 联合碳酸氢钠以及单纯碳酸氢钠动脉内灌注对兔 VX2 肿瘤模型代谢及免疫肿瘤微环境的影响。
将荷 VX2 肝脏肿瘤的兔分为 5 组,分别进行常规 TACE(cTACE)、Idarubicin 载药 OncozeneTM 载药微球(DEE)TACE、Doxorubicin 载药 LUMI™-DEE TACE、cTACE 联合碳酸氢钠及单纯碳酸氢钠动脉内灌注治疗,治疗前后使用 Biosensor Imaging of Redundant Deviation in Shifts(BIRDS)进行 MRI 和细胞外 pH 值(pH)图谱检测,并与未经治疗的兔或仅接受动脉内碳酸氢钠治疗的兔进行比较。采用免疫组化染色(PCNA、TUNEL)和免疫反应(HLA-DR、CD3)检测细胞活力,验证成像结果。采用 Mann-Whitney U 检验进行统计学分析。
pH 值图谱显示,与对照组(p=0.0175)和 cTACE 组(p=0.0025)相比,cTACE 联合碳酸氢钠灌注可显著增加肿瘤 pH 值。对照组肿瘤旁可见 HLA-DR 抗原呈递细胞和 CD3+T 淋巴细胞聚集,cTACE 治疗的肿瘤免疫浸润减少,而与碳酸氢钠联合应用可恢复免疫浸润。DEE-TACE 联合 OncozeneTM 载药微球可引起中等强度的肿瘤内和显著的肿瘤旁浸润,而碳酸氢钠联合应用可使浸润程度略有降低。与单独使用 LUMI™-载药微球相比,在使用 LUMI™-载药微球前预先给予碳酸氢钠可增强肿瘤旁免疫细胞浸润,并导致所有治疗组中最强的肿瘤内免疫细胞浸润。
TACE 中化疗栓塞方案的选择强烈影响治疗后 TME pH 值以及免疫细胞在肿瘤组织中聚集和浸润的能力。
联合常规经动脉化疗和碳酸氢钠灌注可使 pH 值向更接近生理值的方向移动(p=0.0025)。
经动脉化疗后抗原呈递细胞和 T 淋巴细胞在肿瘤旁和肿瘤内的浸润模式取决于化疗栓塞方案的选择。
经动脉治疗联合 Doxorubicin 载药 LUMI™-载药微球和碳酸氢钠灌注可使肿瘤内免疫细胞的存在最强(HLA-DR 细胞的阳性指数为 0.47,CD3 细胞为 0.62)。